Nursing interventions applied to a person with ischemic CVE secondary to SARS-CoV-2 infection
DOI:
https://doi.org/10.51422/ren.v22i2.391Keywords:
SARS-CoV-2, ´post-acute COVID-19 sequelae, risk factors, thrombosis, cytokine release syndrome, strokeAbstract
Introduction: This case study showcases the impact of SARS-CoV-2 infection, particularly its neurological manifestations, which include anosmia, ageusia, adynamia, confusion, altered consciousness and alterations in cerebral circulation, which can lead to sequelae such as ischemic stroke (CVD).
Objective: To apply specialized interventions and actions to a patient with a SARS-CoV-2-related ischemic stroke (CVD) based on Dorothea Orem’s Self-Care Deficit Nursing Theory.
Materials and Methods: A neurological assessment of the patient was conducted through the use of an assessment tool developed by Neurological Nursing postgraduate students based on the universal self-care deficits proposed by Dorothea Orem. A holistic follow up was maintained, and care was provided in line with specific intervention plans for the presented alterations.
Description of the clinical case: Patient diagnosed with (CVD) ischemic stroke of the left-middle cerebral artery. Due to the patient’s health condition at the time of the application of the assessment instrument, the acquisition of data was supported by the responsible person through their informed consent.
Relevance: COVID-19, caused by SARS-CoV-2 infection, is characterized by the virus’ affinity to ACE2 receptors present throughout the human body. Due to the multiple receptors of this type it retains, the brain portrays specific symptoms. This leads to neurological conditions that, depending on the the severity of the disease, could result in lasting sequelae on the infected person.
Conclusions: Due to the specialized care they provide in the process of stabilization and recovery, nursing personnel plays a critical role in the care of individuals infected with SARS-CoV-2
Downloads
References
García-Azorín D, Ezpeleta D. Breve introducción histórica. En: Ezpeleta D, García-Azorín D, editores. Manual COVID-19 para el neurólogo general [Internet]. Madrid: Ediciones Sen; 2020. p. 8-11. Disponible en: https://cutt.ly/VwP8mIL8
Bender-Del Busto JE, León-Castellón R, Mendieta-Pedroso MD. Enfermedad cerebrovascular y COVID-19. An Acad Cienc Cuba [Internet]. 2020;10(2). Disponible en: https://cutt.ly/cwP8QxVb
Carod-Artal FJ. Complicaciones neurológicas por coronavirus y COVID-19. Rev Neurol [Internet]. 2020;70(9):311-22. doi: 10.33588/rn.7009.2020179 DOI: https://doi.org/10.33588/rn.7009.2020179
Fernández-Jiménez E, Silva-Espinoza C. Revisión bibliográfica: tormenta de citoquinas producida por COVID-19. ID [Internet]. 2020;12(1):42-9. doi: 10.31243/id.v12.2020.987 DOI: https://doi.org/10.31243/id.v12.2020.987
López-Jiménez JJ, Carrillo-Núñez GG, Enríquez-Nicasio P, Mojarro-Velazco M, Ramos-Ibarra ML, Fletes-Rayas AL. Tropismos tisulares en COVID-19. En: Martínez-López E, Pereira-Suárez AL, coordinadoras. COVID-19: Una visión integral aspectos biológicos y psicosociales desde el ámbito universitario [Internet]. Guadalajara: Fondo editorial universitario; 2021. p. 49-64. Disponible en: https://cutt.ly/owP8Rzyo
Matías-Guiu J, Gómez-Pinedo U, Montero-Escribano P, Gómez-Iglesias P, Porta-Etessam J, Matías-Guiu JA. ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2? Neurología [Internet]. 2020;35(3):170-5. doi: 10.1016/j.nrl.2020.03.001 DOI: https://doi.org/10.1016/j.nrl.2020.03.001
Araya-Quintanilla F, Valdés-Orrego I, Gutiérrez-Espinoza H. Sustancia P, citocinas proinflamatorias, receptor de potencial transitorio vaniloide tipo 1 y COVID-19: una hipótesis de trabajo. Neurología. 2021;36(2):184-5. DOI: https://doi.org/10.1016/j.nrl.2020.10.004
Cuevas-García C, Calderón-Vallejo A, Berrón-Ruiz L. La neurología de COVID-19. Rev Alerg Mex [Internet]. 2020;67(4):338-49. Disponible en: https://cutt.ly/YwP8UxVq DOI: https://doi.org/10.29262/ram.v67i4.828
Alarco R, Huarcaya-Victoria J. Potenciales mecanismos de neuroinvasión del SARSCoV-2: una revisión de la literatura actual. Rev Neuropsiquiatr [Internet]. 2021;84(1):25-32. doi: 10.20453/rnp.v84i1.3935 DOI: https://doi.org/10.20453/rnp.v84i1.3935
Organización Mundial de la Salud. Manejo clínico de la COVID-19. Orientaciones evolutivas 25 de enero de 2021. Ginebra: Organización Mundial de la Salud; 2021. Disponible en: https://cutt.ly/CwP8Igbd DOI: https://doi.org/10.56085/01238590.541
Vique-Sánchez JL, Galindo-Hernández O. México con mayor riesgo ante el COVID-19, factores de riesgo que pueden aumentar la ECA2. Nutr Clin Diet Hosp [Internet]. 2021;41(1):55-60. doi: 10.12873/411vique
Rodríguez-Rodríguez LC, Núñez-Luna V. Fisiopatología y manifestaciones clínicas SARS COVID (Covid 19). Fundación Benaim [Internet]. 2020;30(8):8-15. Disponible en: https://cutt.ly/VwP8I8MT
Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol [Internet]. 2023;64(1):66-74. doi: 10.1007/s12016-021-08848-3 DOI: https://doi.org/10.1007/s12016-021-08848-3
López-Sampalo A, Bernal-López MR, Gómez-Huelgas R. Síndrome de COVID-19 persistente. Una revisión narrativa. Rev Clin Esp [Internet]. 2021;222(4):241-50. doi: 10.1016/j.rce.2021.10.003 DOI: https://doi.org/10.1016/j.rce.2021.10.003
Leyva-Rendón A, Hernández-Méndez N. COVID-19: Fisiopatología y complicaciones cerebrovasculares. ICTUS [Internet]. 2021;2(3):e05092102018. Disponible en: https://www.medicinaclinica.org/index.php/ictus/article/view/348
Curay-Macas TS. Complicaciones en pacientes hospitalizados con evento cerebro vascular isquémico (Tesis de grado). Guayaquil: Universidad de Guayaquil; 2018.
Lizano-Salas M, McDonald-Molina C, Tully-Sancho S. Fisiopatología de la cascada isquémica y su influencia en la isquemia cerebral. Rev Med Sinerg [Internet]. 2020;5(8):e555. doi: 10.31434/rms.v5i8.555 DOI: https://doi.org/10.31434/rms.v5i8.555
Pineda-Sanabria JP, Tolosa-Cubillos JM. Accidente cerebrovascular isquémico de la arteria cerebral media. Repert Med Cir [Internet]. 2022;31(1):20-32. doi: 10.31260/RepertMedCir.01217372.1104 DOI: https://doi.org/10.31260/RepertMedCir.01217372.1104
Moya-Guerrero I, Arboleda-Demera J, Guananga-Coba A, Freire-Córdova M, De la Cruz-Espinosa V, Erazo-Verdugo E, et al. Explorando el vínculo entre la enfermedad cerebrovascular y la COVID-19. Arch Venez Farmacol Ter [Internet]. 2021;40(4):361-7. doi: 10.5281/zenodo.5223524
Escobar-Castellanos B, Cid-Henríquez P. El cuidado de enfermería y la ética derivados del avance tecnológico en salud. Acta bioeth [Internet]. 2018;24(1):39-46. doi: 10.4067/S1726-569X2018000100039 DOI: https://doi.org/10.4067/S1726-569X2018000100039
Sánchez-Gallardo A, Cabrera-Godoy FJ, Sánchez-Gallardo A. Enfermería en la Unidad de Cuidados Intensivos: valoración neurológica. En: Pérez-Fuentes MC, Gázquez JJ, Molero MM, Barragán AB, Martos A, Simón MM, et al., compiladores. Avances de investigación en salud a lo largo del ciclo vital. Volumen II [Internet]. Salvador: ASUNIVEP; 2018. p. 229-34. Disponible en: https://cutt.ly/lwP8A7eG
Díaz-Ávila A, Intriago-Ruíz C. Guía para un Plan de egreso en personas con secuelas de enfermedad vascular cerebral. Enferm Univ [Internet]. 2019:16(4):452-64. doi: 10.22201/eneo.23958421e.2019.4.746 DOI: https://doi.org/10.22201/eneo.23958421e.2019.4.746
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista de Enfermería Neurológica
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
